Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07754123
What this trial is testing

Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Hansoh Pharmaceutical Co., Ltd. 206
Testing effectiveness (Phase 2)Study completedNCT00818441
What this trial is testing

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Who this might be right for
Carcinoma, Non-small Cell
Pfizer 119
Not applicableStudy completedNCT06950996
What this trial is testing

A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum

Who this might be right for
Breast CancerLung Cancer, Non-Small CellColon Cancer+2 more
Instituto de Investigacion Sanitaria La Fe 300
Not applicableUnknownNCT03838588
What this trial is testing

The Tracking Molecular Evolution for NSCLC (T-MENC) Study

Who this might be right for
Lung NeoplasmsLung CancerNonsmall Cell Lung Cancer+1 more
Geneplus-Beijing Co. Ltd. 200
Early research (Phase 1)Active Not RecruitingNCT06268613
What this trial is testing

Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIIA
Samsung Bioepis Co., Ltd. 163
Large-scale testing (Phase 3)Looking for participantsNCT07416994
What this trial is testing

Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 440
Testing effectiveness (Phase 2)Study completedNCT00855894
What this trial is testing

The Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 41
Large-scale testing (Phase 3)Study completedNCT00017459
What this trial is testing

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sanofi
Not applicableNot Yet RecruitingNCT06986291
What this trial is testing

Radiation-induced Toxicity of the Heart

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
Technische Universität Dresden 325
Very early researchEnded earlyNCT01707823
What this trial is testing

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung Cancer+5 more
Vanderbilt-Ingram Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT03732846
What this trial is testing

Anlotinib in Treatment of Recurrent Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 43
Large-scale testing (Phase 3)Study completedNCT01168973
What this trial is testing

Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 1,253
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05703997
What this trial is testing

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

Who this might be right for
Small Cell Lung Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Testing effectiveness (Phase 2)Ended earlyNCT04027946
What this trial is testing

LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung CancerAdenocarcinoma of Lung
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787613
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

Who this might be right for
NSCLC Stage IV
Shanghai Henlius Biotech 132
Early research (Phase 1)Active Not RecruitingNCT05364073
What this trial is testing

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Not applicableUnknownNCT04948047
What this trial is testing

Breath Combined With CT for Diagnoses of Pulmonary Nodules

Who this might be right for
Non-small Cell Lung CancerPulmonary Nodule, Multiple
Peking University People's Hospital 900
Early research (Phase 1)Ended earlyNCT04510415
What this trial is testing

Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 2
Next Page